HighTower Advisors
ESPR

HighTower Advisors’s Esperion Therapeutics ESPR Stock Holding History

HighTower Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,500
Closed -$6.18K – 3844
2024
Q4 		$6.18K Buy
19,500
+2,500
+15% +$5.83K ﹤0.01% 3618
2024
Q3 		$4.25K Buy
17,000
+4,000
+31% +$8.08K ﹤0.01% 3601
2024
Q2 		$11.4K Buy
13,000
+2,800
+27% +$6.59K ﹤0.01% 3434
2024
Q1 		$3.54K Buy
+10,200
New +$24.8K ﹤0.01% 3459
2020
Q3 		– Sell
-1,000
Closed -$22K – 2588
2020
Q2 		$22K Sell
1,000
-2,400
-71% -$100K ﹤0.01% 2253
2020
Q1 		$30K Buy
3,400
+600
+21% +$31.7K ﹤0.01% 2048
2019
Q4 		$83K Buy
2,800
+600
+27% +$27K ﹤0.01% 2092
2019
Q3 		$25K Buy
+2,200
New +$87.1K ﹤0.01% 2256

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return